Estimation of dose determination method for erythropoiesis-stimulating agents

Estimation of dose determination method for erythropoiesis-stimulating agents - Estimation of dose determination method for erythropoiesis-stimulating agents

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033555

Enrollment

120

Registered

2018-07-31

Start date

2018-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal anemia

Interventions

Renal anemia treatments continuously using dose determination method for erythropoiesis-stimulating agents. Duration: Six months. Usual renal anemia treatments not using dose determination method fo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis duration: 3 months or more. Erythropoiesis-stimulating agents treatments: 3 months or more.

Exclusion criteria

Exclusion criteria: Severe heart failure Uncontrolled Hypertension Non-renal anemia Bleeding needing blood transfusion within 3 months. Major surgery within 6 months. CRP levels of 3 mg/L or more.

Design outcomes

Primary

Measure	Time frame
Hemoglobin levels stability	—

Secondary

Measure	Time frame
Dose and efficiency of erythropoiesis-stimulating agents	—

Countries

Japan

Contacts

Public ContactTetsuya Fujikawa

Yokohama national university Center for health service sciences

tftf@ynu.ac.jp0453393153

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026